Date:
Time:
Investors can register for the conference HERE.
Following the conference, a webcast replay of the presentation will be available on the Investor section of the company’s website, electroCore.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Investors:Rich Cockrell CG Capital 404-736-3838 ecor@cg.capital or Media Contact:Jackie Dorsky electroCore 908-313-6331 Jackie.dorsky@electrocore.com
Source: electroCore, Inc.
2022 GlobeNewswire, Inc., source